Travatan Versus Timoptic in Treating Open-angle Glaucoma or Ocular Hypertension
Status:
Completed
Trial end date:
2008-04-01
Target enrollment:
Participant gender:
Summary
To evaluate the Intraocular Pressure (IOP) lowering efficacy and safety of Travoprost 0.004%
compared to Timolol 0.5% in patients with open-angle glaucoma (OAG) or ocular hypertension
(OH). The study structure is a parallel design. The patients will receive treatment for 12
weeks.